Expired contract
Complementary cancer therapy May 2023 to April 2025
Details
- Supplier(s)
- Cavendish Cancer Care
- Value
- GBP 40,509
- Duration
- 2 years
- Topic
- Outpatient care services
- Published
- 27 June 2023
- Source
- uk:contracts_finder
Tender description
Complementary cancer therapy May 2023 to April 2025
Timeline
- Completed: Award date1 May 2023
- Completed: Award published27 June 2023Current notice
- Completed: Contract expiry date30 April 2025
About the buyer
Chesterfield Royal Hospital NHS Foundation Trust is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.
Relevant CPV codes
- 85112200 · Outpatient care services
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@chesterfield-royal-hospital-nhs-foundation-trust.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@chesterfield-royal-hospital-nhs-foundation-trust.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@chesterfield-royal-hospital-nhs-foundation-trust.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@chesterfield-royal-hospital-nhs-foundation-trust.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@chesterfield-royal-hospital-nhs-foundation-trust.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@chesterfield-royal-hospital-nhs-foundation-trust.gov |
4 similar open tenders
See more open tenders related to Complementary cancer therapy May 2023 to April 2025.
- Open tender
Public Healthcare - Outsourcing DPS
- Open tender
Public Healthcare - Outsourcing DPS
Related buyers
Buyers similar to Chesterfield Royal Hospital NHS Foundation Trust.
BuyersCountValue
- 510£239.0m
- 380£5.3bn
- 255£44.8m
- 226£133.8m
- 225£25.7m
- 223£225.1m
- 214£11.7m
- 207£130.8m
- 173£11.2bn
- 172£46.2m
Win more public sector contracts
Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.
